Assessment of capsule endoscopy scoring index, clinical disease activity, and C-reactive protein in small bowel Crohn's disease

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue 5, 2013, Pages 829-833

  Yang, Li ^a   Ge, Zhi Zheng ^a   Gao, Yun Jie ^a   Li, Xiao Bo ^a   Dai, Jun ^a   Zhang, Yao ^a   Xue, Han Bing ^a   Zhao, Yun Jia ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

C reactive protein; Capsule endoscopy scoring index; Harvey Bradshaw index; Small bowel Crohn's disease

Indexed keywords

C REACTIVE PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CAPSULE ENDOSCOPY; CAPSULE ENDOSCOPY SCORING INDEX; CLINICAL ASSESSMENT TOOL; CLINICAL DISEASE ACTIVITY INDEX; CLINICAL EVALUATION; CROHN DISEASE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HARVEY BRADSHAW INDEX; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMALL BOWEL CROHN DISEASE;

EID: 84876962591     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12146     Document Type: Article

References (18)

1. Tukey M, Pleskow D, Legnani P etal. The utility of capsule endoscopy in patients with suspected Crohn's disease. Am. J. Gastroenterol. 2009; 104: 2734-2739.
2. Solem CA, Loftus EV Jr, Fletcher JG etal. Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial. Gastrointest. Endosc. 2008; 68: 255-266.
3. Efthymiou A, Viazis N, Vlachogiannakos J etal. Wireless capsule endoscopy versus enteroclysis in the diagnosis of small-bowel Crohn's disease. Eur. J. Gastroenterol. Hepatol. 2009; 21: 866-871.
4. Bourreille A, Ignjatovic A, Aabakken L. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus. Endoscopy 2009; 41: 618-637.
5. Gralnek IM, Defranchis R, Seidman E etal. Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change. Aliment. Pharmacol. Ther. 2008; 27: 146-154.
6. Satsangi J, Silverberg MS, Vermeire S etal. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006; 55: 749-753.
7. Marco D, Geert DH, Gert VA. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest. Endosc. 2004; 60: 505-512.
8. Gomes P, du Boulay C, Smith CL etal. Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut 1986; 27: 92-95.
9. Cellier C, Sahmoud T, Froguel E etal. Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Gut 1994; 35: 231-235.
10. Solem CA, Loftus EV Jr, Tremaine WJ etal. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm. Bowel Dis. 2005; 11: 707-712.
11. Aggarwal V, Andrew SD, Susan J etal. Capsule endoscopy findings in small bowel Crohn's disease patients in clinical remission: correlation with the Crohn's Disease Activity Index. Gastroenterology 2010; 138: S1-114.
12. Karoui S, Ouerdiane M, Serghini M etal. Correlation between levels of C-reactive protein and clinical activity in Crohn's disease. Dig. Liver Dis. 2007; 39: 1006-1010.
13. Henriksen M, Jahnsen J, Lygren I etal. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Gut 2008; 57: 1518-1523.
14. Langhorst J, Elsenbruch S, Koelzer J etal. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP and clinical indices. Am. J. Gastroenterol. 2008; 103: 162-169.
15. Schoepfer A, Beglinger C, Straumann A etal. Fecal calprotectin correlates more closely with the simple endoscopic score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI. Am. J. Gastroenterol. 2010; 105: 162-169.
16. Guillaume PC, Laurent PB, Marc L etal. Clinical implications of mucosal healing for the management of IBD. Gatroenterol. Hepatol. 2010; 7: 15-29.
17. Minderhoud IM, Samsom M, Oldenburg B etal. What predicts mucosal inflammation in Crohn's disease patients? Inflamm. Bowel Dis. 2007; 13: 1567-1572.
18. Assche GV, Dignass A, Panes J etal. The second European evidence-based consensus on the diagnosis and management of Crohn's disease. J. Crohns Colitis 2010; 4: 7-27.